Advertisement

Ads Placeholder
Loading...

RadNet, Inc.

RDNT•NASDAQ
Healthcare
Medical - Diagnostics & Research
$54.79
$-0.52(-0.94%)
U.S. Market opens in 19h 51m

RadNet, Inc. (RDNT) Stock Overview

Explore RadNet, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.3B
P/E Ratio-220.87
EPS (TTM)$-0.25
ROE-0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$62.70
3 Months$67.28
1 Year Target$91.44

RDNT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of RadNet, Inc. (RDNT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.82, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $91.44.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -220.87 and a market capitalization of 4.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.94%
5-Day Change
-6.29%
1-Month Change
-24.51%
3-Month Change
-22.78%
6-Month Change
-29.43%
Year-to-Date (YTD) Change
-22.78%
1-Year Change
10.66%
3-Year Change
117.68%
5-Year Change
145.36%
All-Time (Max) Change
7304.05%

Contact Information

https://www.radnet.com
310 478 7808
1508, 1510 and 1516 Cotner Avenue, Los Angeles, CA, 90025-3303

Company Facts

110,000 Employees
IPO DateJan 3, 1997
CountryUS
Actively Trading

Frequently Asked Questions